ArticleCardiology and therapy2020

A Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 Studies.

Michael J Koren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.